Bovine lactoferrin in preventing preterm delivery associated with sterile inflammation

Biochemistry and Cell Biology

Volumn 90, Issue 3, 2012, Pages 468-475

  Paesano, Rosalba ^a,b   Pietropaoli, Miriam ^c   Berlutti, Francesca ^a   Valenti, Piera ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Clinica Fabia Mater   (Italy)

^c Biotechnology Company   (Italy)

Author keywords

Anemia; IL 6; Inflammation; Lactoferrin; Preterm delivery

Indexed keywords

ANEMIA; IL-6; INFLAMMATION; LACTOFERRIN; PRETERM DELIVERY;

BODY FLUIDS; IRON; MAMMALS; PHYSIOLOGY;

PATHOLOGY;

BOVINE LACTOFERRIN; FERRITIN; FIBRONECTIN; HEMOGLOBIN; INTERLEUKIN 6; IRON; LACTOFERRIN; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CERVICAL LENGTH MEASUREMENT; DELIVERY; DRUG EFFECT; DRUG SAFETY; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; FETUS; GESTATIONAL AGE; HEMATOLOGICAL PARAMETERS; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; NEWBORN; OUTCOME ASSESSMENT; PREGNANT WOMAN; PREMATURE LABOR; PROTEIN BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX MUCUS; UTERUS CONTRACTILITY;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; ANIMALS; CATTLE; CERVIX UTERI; DINOPROST; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-6; LACTOFERRIN; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; RISK FACTORS; TREATMENT OUTCOME; UTERINE CERVICITIS;

BOVINAE;

EID: 84861408311     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o11-060     Document Type: Article

References (35)

1. Apgar V. 1953. A proposal for a new method of evaluation of the newborn infant. Curr. Res. Anesth. Analg. 32 (4): 260-267. 13083014
2. Baker E.N. Baker H.M. 2005. Molecular structure, binding properties and dynamics of lactoferrin. Cell. Mol. Life Sci. 62 (22): 2531-2539. 10.1007/s00018-005-5368-9 16261257
3. Bromer J.G. Ata B. Seli M. Lockwood C.J. Seli E. 2011. Preterm deliveries that result from multiple pregnancies associated with assisted reproductive technologies in the USA: a cost analysis. Curr. Opin. Obstet. Gynecol. 23 (3): 168-173. 10.1097/GCO.0b013e32834551cd 21372712
4. Christiaens I. Zaragoza D.B. Guilbert L. Robertson S.A. Mitchell B.F. Olson D.M. 2008. Inflammatory processes in preterm and term parturition. J. Reprod. Immunol. 79 (1): 50-57. 10.1016/j.jri.2008.04.002 18550178
5. Estrada-Gutierrez G. Gomez-Lopez N. Zaga-Clavellina V. Giono-Cerezo S. Espejel-Nunez A. Gonzalez-Jimenez M.A. et al. 2010. Interaction between pathogenic bacteria and intrauterine leukocytes triggers alternative molecular signaling cascades leading to labor in women. Infect. Immun. 78 (11): 4792-4799. 10.1128/IAI.00522-10 20805331
6. Genc M.R. Ford C.E. 2010. The clinical use of inflammatory markers during pregnancy. Curr. Opin. Obstet. Gynecol. 22 (2): 116-121. 10.1097/GCO. 0b013e3283374ac8 20139764
7. Goepfert A.R. Goldenberg R.L. Andrews W.W. Hauth J.C. Mercer B. Iams J. et al. 2001. The preterm prediction study: association between cervical interleukin 6 concentration and spontaneous preterm birth. Am. J. Obstet. Gynecol. 184 (3): 483-488. 10.1067/mob.2001.109653 11228507
8. Goldenberg R.L. Culhane J.F. Iams J.D. Romero R. 2008. Epidemiology and causes of preterm birth. Lancet, 371 (9606): 75-84. 10.1016/S0140-6736(08)60074- 4 18177778
9. Gotsch F. Gotsch F. Romero R. Erez O. Vaisbuch E. Kusanovic J.P. et al. 2009. The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J. Matern. Fetal Neonatal Med. 22 (S2): 5-23. 10.1080/14767050902860690 19951079
10. Heinrich P.C. Behrmann I. Haan S. Hermanns H.M. Müller-Newen G. Schaper F. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (1): 1-20. 10.1042/BJ20030407 12773095
11. Houben M.L. Nikkels P.G.J. van Bleek G.M. Visser G.H.A. Rovers M.M. Kessel H. et al. 2009. The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS ONE, 4 (8): e6572. 10.1371/journal.pone.0006572 19668329
12. Krupa F.G. Faltin D. Cecatti J.G. Surita F.G.C. Souza J.P. 2006. Predictors of preterm birth. Int. J. Gynaecol. Obstet. 94 (1): 5-11. 10.1016/j.ijgo.2006.03.022 16730012
13. Lee S.Y. Buhimschi I.A. Dulay A.T. Ali U.A. Zhao G. Abdel-Razeq S.S. et al. 2011. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. J. Immunol. 186 (5): 3226-3236. 10.4049/jimmunol.1003587 21282511
14. Leitich H. Bodner-Adler B. Brunbauer M. Kaider A. Egarter C. Husslein P. 2003. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am. J. Obstet. Gynecol. 189 (1): 139-147. 10.1067/mob.2003.339 12861153
15. Lim K. Butt K. Crane J.M. 2011. Ultrasonographic cervical length assessment in predicting preterm birth in singleton pregnancies. J. Obstet. Gynaecol. Can. 33 (5): 486-499. 21639971
16. Lyon D. Cheng C.Y. Howland L. Rattican D. Jallo N. Pickler R. et al. 2010. Integrated review of cytokines in maternal, cord, and newborn blood: part I'associations with preterm birth. Biol. Res. Nurs. 11 (4): 371-376. 10.1177/1099800409344620 20034950
17. McEwan M. Lins R.J. Munro S.K.Z. Vincent L. Ponnampalam A.P. Mitchell M.D. 2009. Cytokine regulation during the formation of the fetalmaternal interface: focus on cell-cell adhesion and remodelling of the extracellular matrix. Cytokine Growth Factor Rev. 20 (3): 241-249. 10.1016/j.cytogfr.2009.05. 004 19487153
18. McLoughlin R.M. Jenkins B.J. Grail D. Williams A.S. Fielding C.A. Parker C.R. et al. 2005. IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc. Natl. Acad. Sci. U.S.A. 102 (27): 9589-9594. 10.1073/pnas.0501794102 15976028
19. Mitchell M.D. Dudley D.J. Edwin S.S. Schiller S.L. 1991. Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells. Eur. J. Pharmacol. 192 (1): 189-191. 10.1016/0014-2999(91)90090-D 2040361
20. Murtha A.P. Greig P.C. Jimmerson C.E. Herbert W.N. 1998. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery. Obstet. Gynecol. 91 (2): 161-164. 10.1016/S0029-7844(97)00602-9 9469268
21. Nugent R.P. Krohn M.A. Hillier S.L. 1991. Reliability of diagnosing bacterial vaginosis is improved by standard method of gram stain interpretation. J. Clin. Microbiol. 29 (2): 297-301. 1706728
22. Paesano R. Torcia F. Berlutti F. Pacifici E. Ebano V. Moscarini M. Valenti P. 2006. Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women. Biochem. Cell Biol. 84 (3): 377-380. 10.1139/o06-040 16936810
23. Paesano R. Pietropaoli M. Gessani S. Valenti P. 2009. The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia. Biochimie, 91 (1): 44-51. 10.1016/j.biochi.2008.06.004 18601971
24. Paesano R. Berlutti F. Pietropaoli M. Pantanella F. Pacifici E. Goolsbee W. Valenti P. 2010 a. Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women. Biometals, 23 (3): 411-417. 10.1007/s10534-010-9335-z 20407805
25. Paesano R. Berlutti F. Pietropaoli M. Goolsbee W. Pacifici E. Valenti P. 2010 b. Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women. Int. J. Immunopathol. Pharmacol. 23 (2): 577-587. 20646353
26. Petrozella L.N. Dashe J.S. McIntire D.D. Leveno K.J. 2011. Clinical significance of borderline amniotic fluid index and oligohydramnios in preterm pregnancy. Obstet. Gynecol. 117 (2): 338-342. 10.1097/AOG.0b013e3182056766 21252747
27. Puddu P. Latorre D. Carollo M. Catizone A. Ricci G. Valenti P. Gessani S. 2011. Bovine lactoferrin counteracts toll-like receptor mediated activation signals in antigen presenting cells. PLoS ONE, 6 (7): e22504. 10.1371/journal.pone.0022504 21799877
28. Rose-John S. Waetzig G.H. Scheller J. Grötzinger J. Seegert D. 2007. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin. Ther. Targets, 11 (5): 613-624. 10.1517/14728222.11.5.613 17465721
29. School T.O. 2005. Iron status during pregnancy: setting the stage for mother and infant. Am. J. Clin. Nutr. 81: 1218-1222.
30. Sorokin Y. Romero R. Mele L. Wapner R.J. Iams J.D. Dudley D.J. et al. 2010. Maternal serum interleukin-6, c-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth < 32 weeks and adverse neonatal outcomes. Am. J. Perinatol. 27 (8): 631-640. 10.1055/s-0030-1249366 20195952
31. Strevens H. Allen K. Thornton J.G. 2010. Management of premature prelabor rupture of the membranes. Ann. N.Y. Acad. Sci. 1205 (1): 123-129. 10.1111/j.1749-6632.2010.05654.x 20840263
32. Valenti P. Antonini G. 2005. Lactoferrin: an important host defence against microbial and viral attack. Cell. Mol. Life Sci. 62 (22): 2576-2587. 10.1007/s00018-005-5372-0 16261253
33. Wei S.Q. Fraser W. Luo Z.C. 2010. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet. Gynecol. 116 (2): 393-401. 10.1097/AOG.0b013e3181e6dbc0 20664401
34. Wessling-Resnick M. 2010. Iron homeostasis and the inflammatory response. Annu. Rev. Nutr. 30 (1): 105-122. 10.1146/annurev.nutr.012809.104804 20420524
35. Wrighting D.M. Andrews N.C. 2006. Interleukin-6 induces hepcidin expression through STAT3. Blood, 108 (9): 3204-3209. 10.1182/blood-2006-06- 027631 16835372